Cosopt Interactions
There are 282 drugs known to interact with Cosopt (dorzolamide/timolol ophthalmic), along with 16 disease interactions. Of the total drug interactions, 36 are major, 243 are moderate, and 3 are minor.
- View all 282 medications that may interact with Cosopt
- View Cosopt disease interactions (16)
Most frequently checked interactions
View interaction reports for Cosopt (dorzolamide / timolol ophthalmic) and the medicines listed below.
- Alphagan (brimonidine ophthalmic)
- Alphagan P (brimonidine ophthalmic)
- amlodipine
- aspirin
- atorvastatin
- brimonidine ophthalmic
- Crestor (rosuvastatin)
- furosemide
- gabapentin
- hydrochlorothiazide
- Lasix (furosemide)
- latanoprost ophthalmic
- levothyroxine
- Lipitor (atorvastatin)
- lisinopril
- losartan
- Lumigan (bimatoprost ophthalmic)
- metformin
- metoprolol
- multivitamin
- omeprazole
- Plavix (clopidogrel)
- prednisone
- simvastatin
- Synthroid (levothyroxine)
- Travatan Z (travoprost ophthalmic)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Xalatan (latanoprost ophthalmic)
Cosopt disease interactions
There are 16 disease interactions with Cosopt (dorzolamide / timolol ophthalmic) which include:
- asthma/COPD
- bradycardia/AV block
- cardiogenic shock
- CHF
- diabetes
- hypersensitivity
- hyperthyroidism
- PVD
- hematologic toxicity
- hypersensitivity reactions
- porphyria
- myasthenia gravis
- crystalluria
- liver disease
- renal dysfunction
- urinary obstruction
More about Cosopt (dorzolamide / timolol ophthalmic)
- Cosopt consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (8)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: ophthalmic glaucoma agents
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.